Article
Clinical and molecular aspects of multiple endocrine neoplasia.
Clinics in laboratory medicine - 1 Mar 1997
Wick M J
Abstract excerpt
The discovery that RET proto-oncogene mutations are responsible for MEN2 and FMTC was a landmark from the perspective of many, including the geneticist involved in basic science, the molecular diagnostician, the clinician, and MEN2/FMTC families. The discovery has provided basic information concerning the role of proto-oncogenes and proto-oncogene activation. The identification of MEN2/FMTC-associated mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
